Companies Dominating the Methotrexate Drugs Market
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Azurity Pharmaceuticals, Inc.
- Cumberland Pharmaceuticals Inc.
- Teva Pharmaceuticals USA, Inc.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma Limited,
- Sandoz Inc
- Hikma Pharmaceuticals PLC
- Eisai Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of methotrexate drugs is estimated at USD 597.64 million.
The methotrexate drugs market size was valued at USD 584.09 million in 2024 and is set to exceed USD 846.99 million by 2037, registering over 2.9% CAGR during the forecast period i.e., between 2025-2037. The surge in the prevalence of rheumatoid arthritis and the increasing prevalence of cancer will drive the market growth.
North America industry is set to hold largest revenue share of 41% by 2037, due to rising demand for methotrexate drugs in the region.
The major players in the market include Pfizer Inc., Azurity Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Sandoz Inc, Hikma Pharmaceuticals PLC, Eisai Co., Ltd.
